XSF-30596-21450
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 665 / KS
- Registered
- 2021-11-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
TZ9-20757-36162
Child or adolescent in my care · Male · 2021-11-20
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2021-11-04
Registered in v-safe
- 2021-11-04
- 2021-11-11
- 2021-11-20
- 2021-11-25
- 2022-01-13
-
2022-10-16
Survey response — 12 months, dose 3MedDRA: Chills, Fatigue, Headache, Pain — Feeling: FairFree text: Achy, tired, headache, chillsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | No |
| 2 | 2021-01-08 | Pfizer-BioNTech | No |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: Achy, tired, headache, chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release